These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2419596)
1. [A case of amylase-producing ovarian tumor]. Tanaka Y; Ueda G; Tanizawa O; Miyake H; Kohno M; Nishiyama S; Inoue H; Ikeuchi H; Sekigawa S; Matsunaga S Gan No Rinsho; 1986 Jan; 32(1):111-6. PubMed ID: 2419596 [TBL] [Abstract][Full Text] [Related]
2. [Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report]. Kawamurra S; Hiura M; Kaneko H; Yokoyama T; Tanaka M; Chiba T; Moriwaki S Gan No Rinsho; 1988 Apr; 34(4):497-504. PubMed ID: 2451762 [TBL] [Abstract][Full Text] [Related]
3. [Neoplasm of the ovary as a cause of hyperamylasemia]. Pose Reino A; Suárez Dono J; Codesido Blanco T; Ferrón Vidán F; Lorenzo González A; Bugallo Paz L An Med Interna; 1989 Apr; 6(4):207-8. PubMed ID: 2485076 [TBL] [Abstract][Full Text] [Related]
4. [Metastatic brain tumor after chemotherapy of ovarian cancer]. Fukuda K; Chen JT; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K; Sakamoto A Gan No Rinsho; 1987 Jan; 33(1):115-8. PubMed ID: 3102810 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and pathological studies on amylase-producing ovarian cancer]. Matsuda M; Izutsu T; Kagabu T; Nishiya I; Iida H; Kubota T Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):935-42. PubMed ID: 2414384 [No Abstract] [Full Text] [Related]
6. An amylase-producing serous cystadenocarcinoma of the ovary. Hodes ME; Sisk CJ; Karn RC; Ehrlich CE; Lehrner LM; Roth LM; Morley DJ; Merritt AD Oncology; 1985; 42(4):242-7. PubMed ID: 2409494 [TBL] [Abstract][Full Text] [Related]
7. [Effects of chemotherapy of advanced malignant ovarian tumors]. Ohta M; Sakakibara K; Casanova H; Nishida Y; Kano T; Tomoda Y; Kazato S; Miyazaki T; Arii Y; Umemura S Gan To Kagaku Ryoho; 1985 Nov; 12(11):2208-15. PubMed ID: 4062320 [TBL] [Abstract][Full Text] [Related]
8. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer]. Ohta M; Tomoda Y; Kano T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004 [TBL] [Abstract][Full Text] [Related]
9. [A case of serous papillary cystadenocarcinoma of the ovary with hyperamylasemia]. Nakamura S; Hirabayashi N; Asai J Gan No Rinsho; 1987 Apr; 33(4):428-33. PubMed ID: 2437341 [TBL] [Abstract][Full Text] [Related]
10. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor]. Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732 [TBL] [Abstract][Full Text] [Related]
11. [A patient with stage IIIc ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intraperitoneal hyperthermic chemoperfusion]. Kobayashi K; Fujimoto S; Takahashi M; Mutou T; Toyosawa T; Ohtsuka Y; Ogasawara T Gan To Kagaku Ryoho; 2003 Oct; 30(11):1726-8. PubMed ID: 14619504 [TBL] [Abstract][Full Text] [Related]
12. [A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil]. Tashiro K; Kondo N; Ikemoto I Hinyokika Kiyo; 1986 Mar; 32(3):449-53. PubMed ID: 3728246 [TBL] [Abstract][Full Text] [Related]
13. [Rare late metastasis of a successfully treated advanced ovarian cancer]. Theissig P; Theissig F; Lotze W Zentralbl Gynakol; 1986; 108(19):1189-92. PubMed ID: 3811669 [TBL] [Abstract][Full Text] [Related]
14. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Silva EG; Gershenson DM; Malpica A; Deavers M Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075 [TBL] [Abstract][Full Text] [Related]
15. Amylase elevation attributable to an ovarian neoplasm. Corlette MB; Dratch M; Sorger K Gastroenterology; 1978 May; 74(5 Pt 1):907-9. PubMed ID: 640346 [TBL] [Abstract][Full Text] [Related]
17. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results. Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406 [TBL] [Abstract][Full Text] [Related]
18. The alterations in the activity of amylase and its salivary isoenzyme in the serum of patients with ovarian carcinoma, submitted to radiotherapy. Zakrzewska I; Pietryńczak M Rocz Akad Med Bialymst; 1997; 42(1):229-35. PubMed ID: 9581485 [TBL] [Abstract][Full Text] [Related]
19. [A case of bilateral metastatic breast carcinoma from gastric carcinoma]. Kasuga Y; Senga O; Hanamura N; Iida F; Oota H; Katsuyama T; Tsuchiya S Gan No Rinsho; 1986 Apr; 32(4):407-12. PubMed ID: 3012143 [TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. Cocconi G; DeLisi V; Di Blasio B Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]